Case T-362/16: Judgment of the General Court of 19 June 2018 — Tillotts Pharma v EUIPO — Ferring (XENASA) (EU trade mark — Opposition proceedings — Application for EU word mark XENASA — Earlier EU word mark PENTASA — Relative ground for refusal — No likelihood of confusion — Article 8(1)(b) of Regulation (EC) No 207/2009 (now Article 8(1)(b) of Regulation (EU) 2017/1001))
Judgment of the General Court of 19 June 2018 — Tillotts Pharma v EUIPO — Ferring (XENASA)
(Case T-362/16) ( 1 )
‛(EU trade mark — Opposition proceedings — Application for EU word mark XENASA — Earlier EU word mark PENTASA — Relative ground for refusal — No likelihood of confusion — Article 8(1)(b) of Regulation (EC) No 207/2009 (now Article 8(1)(b) of Regulation (EU) 2017/1001))’
2018/C 268/38Language of the case: EnglishParties
Applicant: Tillotts Pharma AG (Rheinfelden, Switzerland) (represented by: M. Douglas, lawyer)
Defendant: European Union Intellectual Property Office (represented by: J. Ivanauskas and D. Walicka, acting as Agents)
Other party to the proceedings before the Board of Appeal of EUIPO, intervener before the General Court: Ferring BV (Hoofddorp, Netherlands) (represented initially by: I. Fowler, Solicitor, and D. Slopek, lawyer, and subsequently by I. Fowler)
Re:
Action brought against the decision of the Fourth Board of Appeal of EUIPO of 29 April 2016 (Case R 3264/2014-4), relating to opposition proceedings between Ferring and Tillotts Pharma.
Operative part of the judgment
The Court:
|
1. |
Annuls the decision of the Fourth Board of Appeal of the European Union Intellectual Property Office (EUIPO) of 29 April 2016 (Case R 3264/2014-4); |
|
2. |
Orders EUIPO to bear its own costs and to pay those incurred by Tillotts Pharma AG; |
|
3. |
Orders Ferring BV to bear its own costs. |
( 1 ) OJ C 314, 29.8.2016.